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What is the key message of your article?   
• Intravenous administration of caffeine citrate in ventilated, prematurely born 
neonates transiently increased the diaphragmatic EMG activity and improved 
respiratory function.  
 
What does it add to the existing literature?  
• This is the first study to assess the impact of caffeine on the diaphragmatic EMG 
activity in ventilated neonates. 
 
What is the impact? 
• Our results describe a mechanism by which caffeine administration might facilitate 
extubation of ventilated, prematurely born infants. 
ABSTRACT  
Background: Administration of caffeine citrate can facilitate extubation.  Our aim was to 
determine whether a loading dose of caffeine citrate given to ventilated, preterm infants 
affected the diaphragm electrical activity.  
Methods: Infants < 34 weeks of gestational age were recruited if requiring mechanical 
ventilation and prescribed a loading dose of caffeine citrate. Surface electrodes recorded the 
electrical activity of the diaphragm (dEMG) before and after administration of intravenous 
caffeine citrate. The mean amplitude of the EMG (dEMG) trace and the mean area under the 
EMG curve (aEMGc) were calculated.  
Results: Thirty-two infants were assessed with a median gestational age of 29 (27 to 31) 
weeks. The dEMG amplitude increased, peaking at 25 minutes post administration (p=0.006) 
and the increase in aEMGc (p= 0.004) peaked at 30 minutes, the differences were not 
significant after 60 minutes. At 20 minutes there was an increase in minute volume (p= 
0.034) and a reduction in the peak inspiratory pressure (p= 0.049). 
Conclusion: We have demonstrated a transient increase in both electrical activity of the 
diaphragm and respiratory function following an intravenous loading dose of caffeine citrate.  
 
 
INTRODUCTION 
Mechanical ventilation is frequently used to support very prematurely born infants who have 
immature, underdeveloped lungs and inadequate respiratory drive. Yet, prolonged ventilation 
is associated with complications such as bronchopulmonary dysplasia and pulmonary 
interstitial emphysema (1, 2) and hence, it is important to successfully extubate infants as 
soon as possible.  Caffeine citrate is a methylxanthine and administration can facilitate 
successful extubation through a number of mechanisms (3). Caffeine citrate is a respiratory 
stimulant that acts centrally and antagonises inhibitory adenosine A1 receptors (4). It 
increases the ventilatory response to hypercapnia in preterm infants (5).  Furthermore, 
administration of caffeine citrate can increase respiratory muscle strength and improve lung 
compliance (6). Intravenous caffeine citrate has also been shown to increase the 
diaphragmatic activity of spontaneously breathing preterm infants with a corresponding 
increase in tidal volume (7). Whether, however the effects of caffeine citrate administration 
on diaphragm electrical activity are similar in ventilated, preterm infants is currently 
unknown.  
 
Electromyography (EMG) is a global measure of the neural impulses that are translated into 
muscle fibre action potentials, with the processed signal giving the amplitude of electrical 
activity of a muscle (8). The amplitude of the electrical activity of the diaphragm (EAdi) is 
helpful in monitoring asynchrony and respiratory muscle loading of ventilated patients (8). 
The electrical activity of the diaphragm can also be used to assess neural respiratory drive (9, 
10); inspiratory drive has been shown to increase in response to an increased work of 
breathing (11).  We hypothesised that administration of a loading dose of caffeine citrate to 
ventilated, prematurely born infants would result in an increase in the amplitude of the 
diaphragm electromyogram and improved respiratory function. Our aim was to test those 
hypotheses.  
METHODS 
Study design and subjects 
A prospective, observational cohort study took place between 01/09/2018 and 30/06/2019 at 
the two neonatal units within King’s College Hospital NHS Foundation Trust (KCH), 
London UK. This NHS Foundation Trust comprises of King’s College Hospital, London and 
the Princess Royal University Hospital, Orpington. The London Brent Research Ethics 
Committee approved the study and the parents gave written, informed consent for their infant 
to take part.  
 
Infants born less than 34 weeks of completed gestational age who were prescribed a loading 
dose of caffeine citrate by the clinical team were eligible for recruitment into the study if they 
were receiving invasive mechanical ventilation. Infants with chromosomal or major 
congenital anomalies were excluded. Baseline demographic data were collected including 
gender, ethnicity, antenatal exposure to corticosteroids and magnesium sulphate, gestational 
age and mode of delivery, mode of ventilation prior to caffeine administration and use of 
postnatal surfactant.  
 
At KCH, ventilatory support was delivered by an SLE 6000 ventilator (SLE limited, Croydon 
UK). Preterm infants were usually supported by patient triggered ventilation (PTV) with a 
targeted tidal volume. Targeted-tidal volumes were set between 5-6 mL/kg. The clinical team 
routinely prescribed a 20-minute loading dose caffeine citrate (20mg/kg) to ventilated infants 
less than 34 weeks of gestational age as per Trust guidelines and in agreement with recent 
evidence showing the benefit of early therapy (before day three of postnatal life) in 
decreasing the composite outcome of BPD or all-cause mortality (12). 
Diaphragmatic electrical activity was measured continuously 15 minutes prior to the 
administration of a loading dose of caffeine citrate and until 180 minutes after the loading 
dose. The peak inspiratory pressure, positive end expiratory pressure, expired tidal volume, 
fraction of inspired oxygen, inspiratory time and mean airway pressure were recorded during 
the same time periods as the EMG analysis. 
 
The activity of the diaphragm was measured via transcutaneous electromyography (EMG) of 
the diaphragm using surface electrodes. All infants were assessed in the supine position. The 
transcutaneous diaphragm EMG was monitored using a portable 16-channel digital 
physiological amplifier (Dipha-16; Inbiolab, Groningen, the Netherlands) and three surface 
electrodes (Kendall H59P cloth electrodes; Covidien, Massachusetts). Two electrodes were 
placed vertically in line with the nipples on the right and left chest wall at the costo-
abdominal margin and one electrode placed at the centre of the sternum. The electrodes were 
connected to a portable physiological amplifier (DEMCON; Macawi Medical Systems, the 
Netherlands) that generated raw signals correlating to the diaphragm EMG at a sampling rate 
of 500Hz. The physiological amplifier wirelessly transmitted to a bedside computer running 
Polybench (Applied Biosignals, Weener, Germany).  Raw signals were filtered and processed 
automatically within the Polybench software including the gating technique. The method 
used to filter the cardiac electrical activity was similar to the gating technique described by 
O’Brien (13). EMG data were imported into MATLAB from Poly5 format using the TMSi 
MATLAB Interface (Twente Medical Systems International, Oldenzaal, the Netherlands). 
The complete recording of each infant was reviewed and points at which the infants was 
moving or being handled were identified by the presence of interference to the signal, these 
were excluded from analysis. EMG analyses of periods of 30-second artefact free recordings 
were performed at set time intervals. Three sets of stable 30-second recordings in a time 
period beginning five minutes prior to administration of the loading dose of caffeine citrate 
and at 5, 20, 25, 30, 60, 120 and 180-minute time intervals after the start of the 20-minute 
caffeine citrate loading dose infusion were analysed.  For each artefact free 30-second 
recording, the mean amplitude of the EMG (dEMG) trace and the mean area under the EMG 
curve (aEMGc) (14, 15) were calculated using MATLAB Statistics Toolbox Release 2015b 
(The MathWorks, Inc., Natick, MA, USA). At each time interval, the change from the 
baseline for each measurement was calculated with each infant acting as their own control.  
 
Analysis 
The data were tested for normality using the Shapiro-Wilk test and found to be non-normally 
distributed. Therefore, data are presented as median (IQR) and differences assessed for 
statistical significance using the Wilcoxon rank sum test for paired changes post caffeine 
administration. Statistical analyses were undertaken using SPSS software Version 25 (SPSS 
Inc., Chicago IL).  
 
Sample Size 
A previous study found an increase in median peak electrical activity from 1.42μV to 2.16μV 
in non-ventilated infants following caffeine administration (7), therefore, using an estimated 
sample mean of 1.4μV ± 0.6μV, to detect a 30% difference in peak diaphragm EMG with 
80% power at the 5% significance level a sample of 32 infants was recruited.  
 
RESULTS 
During the study period, 110 infants born less than 34 weeks of completed gestational age 
were admitted to the neonatal unit, 32 were recruited (Figure 1) (Table 1). There were no 
significant differences in gestational age (GA) and birthweight (BW) between the included 
infants and those 15 infants who were eligible but not included (GA: 31.14 (25.0-32.71) 
weeks, p=0.817; BW: 1.15 (0.73-1.91) kg, p=0.71).  In the included infants, the median time 
after birth to caffeine citrate administration was 288 (133-745) minutes (Table 1).  
 
There was a significant increase in dEMG amplitude from baseline following the loading 
dose of caffeine citrate that peaked at 25 minutes post administration (p=0.006), and a 
significant increase in aEMGc from baseline peaking at 30 minutes post administration of 
caffeine citrate (p=0.004). By 60 minutes the loading dose of caffeine citrate had no 
significant effect on the electrical activity of the diaphragm (Figures 2 and 3). At 20 minutes 
there was a significant increase in minute volume (p=0.034) from baseline and significant 
reduction from baseline in the peak inspiratory pressure (p=0.049) and at 30 minutes a 
significant increase in the respiratory rate (p=0.021) from baseline. There were no significant 
changes in tidal volume post caffeine administration (Table 2).  
 
 
 
 
 
 
DISCUSSION 
We have demonstrated that in preterm, ventilated infants there was a significant increase in 
both the dEMG amplitude and aEMGc, which peaked within the first hour following a 
loading dose of caffeine citrate. This transient increase in diaphragmatic electrical activity 
post administration of intravenous caffeine citrate is in agreement with a recent study in non-
ventilated newborns (7). It may be explained by the initial high peak serum levels seen 
shortly after administration of the loading dose of caffeine. The timing of the increase in 
diaphragmatic activity was associated with improvements in lung function as shown by the 
increase in minute volume and decrease in peak inspiratory pressure. 
  
The current study measured electrical activity and not contractions of the diaphragm. One in 
vivo study found, however, that administration of theophylline resulted in an increase in 
minute ventilation, which correlated with an increase in diaphragmatic contractility as well as 
inspiratory diaphragmatic neuromuscular output (16). What is unknown, however, is the 
underlying mechanism by which caffeine acts to enhance this contractile nature. One adult 
study showed an increase in trans-diaphragmatic pressure post caffeine therapy implying that 
caffeine does indeed enhance muscle contractility of the diaphragm (17). It has been 
suggested that caffeine acts centrally by rapidly crossing the blood brain barrier (18) and 
through transmission of neural impulses has subsequent effects on respiratory function 
resulting in increased diaphragmatic muscle activity (19). A further possibility is that caffeine 
increases sarcoplasmic reticulum calcium concentrations (17, 20) and hence enhances the 
activation of contractile proteins by increasing the affinity of calcium activation sites for 
calcium ions (21).  
A previous study described a significant increase in tidal volume post caffeine citrate 
administration in non-invasively ventilated infants, which was shown to correlate with the 
increase in dEMG amplitude (7). The majority of infants in the present study were supported 
with a predetermined targeted tidal volume, hence we would not have expected to see a 
change in the expiratory tidal volume. As lung mechanics change over time, the peak 
inspiratory pressure (PIP) required to achieve a target tidal volume will change. In this study, 
we observed a statistically significant decrease in PIP post caffeine administration with a 
corresponding increase in minute volume with an increase in respiratory rate demonstrating 
the increase in diaphragmatic electrical activity favourably influenced respiratory function.  
 
The elimination half-life of caffeine citrate is 101 hours in infants (22), compared to the three 
to six hour half-life observed in adults (4). It has been shown, however, that there is a high 
variation in the elimination half-life between neonates of relatively similar conceptional ages 
(23). Moreover, one study showed that peak concentrations of both oral and intravenous 
caffeine citrate are observed at between 30 minutes to two hours following administration 
(24). We speculate that the physiological effects of caffeine citrate in our study peaking 
within the first one hour post administration are related to the time to peak effect (Tmax) at the 
peak concentration (Cmax), and not related to the maximum possible effect of the drug (Emax) 
(25).  
 
Our study has strengths and some limitations. This study used non-invasive techniques for 
monitoring, with the use of surface electrodes, which were generally acceptable to parents 
with only two parents declining participation. There is ease and simplicity in using surface 
electrodes and these can be used for infants of all gestational ages (26). Diaphragm 
electromyogram recording by surface electrodes could potentially be susceptible to 
interference from surrounding muscle groups such as intercostal and abdominal. On analysis 
of the traces, however, little interference was seen. This is in agreement with one previous 
study of diaphragm electrical recordings that showed little cross talk of intercostal and 
abdominal muscles with diaphragmatic activity (27).  Interventions such as neonatal 
procedures, nursing cares or position changes were not controlled for due to the acute setting 
and timing of the study, and these may have had some interference on the dEMG signal as 
movement artefacts, however this limitation was accounted for by selecting the closest 30-
second artefact free period at each time interval studied. Overall, we saw a positive response 
in electrical activity following caffeine administration, but the response was variable.  Our 
sample size, unfortunately, precludes sub-group analysis. A further limitation of this study 
was the non-randomisation of infants, but as caffeine has been shown to be beneficial to all 
premature infants (28, 29) it would be unethical to randomise infants.  
 
In conclusion, we have demonstrated that a loading dose of caffeine citrate in ventilated 
preterm infants had a transient increase in the electrical activity of the diaphragm and 
improvement in respiratory function.  The transient nature of the effects we describe have 
implications for neonatal clinicians, that is if extubation is not soon after the loading dose of 
caffeine citrate has been administered, it may be less effective in facilitating extubation, but 
there is no evidence that this would impinge on its proven effects on improving 
neurodevelopmental outcome (30).    
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FIGURE LEGENDS 
 
Figure 1. Consort flow diagram of recruitment process 
Figure 2. Boxplot of percentage change in diaphragm amplitude over time. The ends of each 
box represent the upper and lower quartiles with the median being marked by a horizontal 
line inside the box. The whiskers are the two lines outside the box that extend to the highest 
and lowest observations. 
Figure 3. Boxplot of percentage change in area under the EMG curve over time. The ends of 
each box represent the upper and lower quartiles with the median being marked by a 
horizontal line inside the box. The whiskers are the two lines outside the box that extend to 
the highest and lowest observations. 
Table 1. Baseline demographics  
Data are presented as median (interquartile range) or n (%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GA = 
gestational 
age; BW = birthweight, FiO2 = fraction of inspired oxygen, PEEP = positive end expiratory pressure 
n 32 
Gestational age (weeks) 29.71 (27.27-31.49) 
Birthweight (kg) 1.15 (0.84-1.44) 
Antenatal steroids 29 (90.6) 
Male sex 13 (40.6)  
Apgar Score at: 
1 min 
5 mins 
10 mins 
 
6 (3-7) 
8 (7-9) 
9 (8.3-10) 
Reason for intubation 
Increased FiO2 
Increased work of breathing 
Poor respiratory effort 
Chest x-ray changes 
Apnoea 
 
4 (12.5) 
8 (25) 
11 (34.4) 
1 (3.1) 
8 (25) 
Where intubated 
Delivery suite 
NNU 
 
30 (93.8) 
2 (6.3) 
Time of delivery suite intubation post 
birth (mins) 
6 (4.0-10.3) 
Time post birth to caffeine (mins) 288 (133-746) 
Postnatal surfactant 32 (100) 
Mode of ventilation 
PTV 
SIMV 
Added TTV 
 
30 (93.8) 
2 (6.3) 
28 (87.5) 
FiO2 at the time of study 0.3 (0.23-0.40) 
PEEP (cmH2O) 5.2 (5.0-5.7) 
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Table 2. Diaphragmatic activity and respiratory function before and after a loading dose of caffeine 
Data are presented as median (interquartile range) 
RR = respiratory rate; MV = minute volume; TV = tidal volume; PIP = peak inspiratory pressure 
 
 
 
Baseline 5 mins 20 mins 25 mins 30 mins 1 hour 2 hours 3 hours 
dEMG 
(µV) 
1.60 (0.77-
2.25) 
1.72 (0.84-
2.67), p=0.015 
1.63 (0.87-
2.45), p=0.217 
2.01 (0.92-2.52), 
p=0.006 
1.96 (0.98-2.40), 
p=0.011 
1.53 (0.82-2.45), 
p=0.295 
1.47 (0.78-
2.26), p=0.517 
1.43 (0.82-2.19), 
p=0.792 
aEMGc 
(µV.S) 
2.39 (1.58-
2.66) 
2.69 (2.02-
3.15), p<0.001 
2.40 (1.68-
3.16), p=0.115 
2.58 (1.95-3.18), 
p=0.005 
2.59 (1.96-3.27), 
p=0.004 
2.33 (1.74-2.96), 
p=0.231 
2.29 (1.70-
2.86), p=0.735 
2.53 (1.79-2.91), 
p=0.360 
RR (bpm) 56.0 (42.7-
70.7) 
56.4 (48.0-
67.9), p=0.455 
60.4 (53.8-
79.5), p=0.152 
50.5 (39.9-61.8), 
p=0.164 
61.5 (45.0-73.6), 
p=0.021 
57.5 (40.1-73.1), 
p=0.902 
65.7 (53.4-
77.9), p=0.069 
60.5 (51.9-73.0), 
p=0.645 
MV 
(mL/min) 
377.5 (224.6-
502.5) 
320 (220.0-
480.0), 
p=0.479 
395.6 (282.0-
528.0), p=0.034 
405.26 (247.8-
517.5), p=0.124 
380.0 (227.7-
500.0), p=0.163 
369.9 (231.8-
528.9), p=0.759 
370 (247.2-
530.0), p=0.469 
410.0 (270.0-
510.0), p=0.879 
TV (mL) 6.4 (4.9-8.1) 6.1 (4.28-
7.35), p=0.974 
6.7 (4.98-7.63), 
p=0.524 
6.9 (4.7-7.7), 
p=0.401 
6.1 (4.8-7.8), 
p=1.0 
6.25 (4.8-8.3), 
p=0.642 
5.7 (4.53-7.33), 
p=-0.249 
5.5 (4.1-7.8), 
p=0.318 
PIP 
(cmH2O) 
16.7 (12.1-
20.0) 
16.8 (12.8-
20.0), p=0.638 
12.9 (10.3-
19.8), p=0.049 
15.3 (13.8-20.0), 
p=0.912 
15.9 (12.1-20.0), 
p=0.737 
16.6 (11.6-19.8), 
p=0.935 
16.3 (11.2-
20.0), p=0.470 
16.1 (11.4-20.0), 
p=0.623 
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